International Pharmaceutical Expo, the premier industry event dedicated to showcasing...
GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH announced the expansion of...
Ventana, a member of the Roche Group, announced it has entered into a master collaboration...
Watson-Marlow Fluid Technology Group strengthens its biopharmaceutical offering through the acquisition of ASEPCO Corporation (Asepco).
Merck's agreement with AIAC is to sell the manufacturing facility in Arecibo that was under closing plans. AIAC will retain the approximately 200 Merck employees.
Just as calibration needs to be part of your quality processes, it absolutely needs to be part of your asset performance management (APM) strategy as well.
Sampson and his three partners in Chicago-based Cresco Labs are switching livelihoods and risking millions of dollars to follow the promise of medical marijuana.
The cash payment under the Nektar-AstraZeneca agreement was triggered by the first commercial sale of MOVANTIK (naloxegol) in the U.S.
Cellceutix Corporation, a clinical stage biopharmaceutical company, has signed a $30 million stock purchase agreement with Aspire Capital Fund, LLC.
Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed.
Analyst Rob Goldman says mid-stage biotech companies are being built for potential sale, in an environment of increasing mergers and acquisitions.
Patheon has closed the transaction to acquire IRIX Pharmaceuticals, a company that specializes in making difficult to manufacture Active Pharmaceutical Ingredients (API).
Ajinomoto Althea announced today that it has added two more top pharmaceutical companies to its growing list of partners in developing and manufacturing cGMP-produced crystal-based drug products.
HHS awarded approximately $12 million today to BioCryst Pharmaceuticals of Durham, North Carolina, for the advanced development of a promising experimental drug for Ebola, including preparing for large-scale manufacturing of the drug and conducting related studies.
Actavis PLC is selling its generic drug business in Australia to privately-held Amneal Pharmaceuticals for an undisclosed amount.
Introducing a stainless steel version of the WLC60 heavy-duty LED lights, designed for use in extremely harsh conditions.
The MIT Center for Biomedical Innovation (CBI) announces a collaboration with the Amgen Foundation to develop the Amgen-MIT Biomanufacturing Educational Initiative, focused on biologics manufacturing.
A recently published market report indicates that the use of robots in a number of industries has more than tripled in the past five years and by 2018, robots are projected to be used for 27 percent of new line installations for medical device primary packaging. For the pharmaceutical industry, robots are expected to service 34 percent of primary packaging efforts, a 13 percent increase from 2013.
Fifty years ago, rommelag revolutionized plastic packaging technology with BFS.
The March issue of Pharmaceutical Processing is our INTERPHEX 2014 show issue and features numerous highlights from show exhibitors. In addition, we also announce the winners in our new Facility Excellence Awards program.
The Caliber Biotherapeutics manufacturing facility in Bryan, Texas offers an interesting look at the development and integration of Plant Made Pharmaceuticals. This commitment to new and innovative drug development strategies has led to it being recognized as one of Pharmaceutical Processing’s Facility Excellence Award winners for 2014.
New development technologies, expanded contract manufacturing and service capabilities, as well as innovative equipment investment strategies highlight leading practices from the best in pharmaceutical processing comprise the 2014 Pharmaceutical Processing Facility Excellence Award winners.
GW Pharmaceuticals plc today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Application Serial Number 13/606,742, a patent application directed to the spray device of its Sativex® product formulation.
This free white paper, 5 Must Have Strategies for Enterprise Quality, shows how quality can take a more prominent, enterprise-scale role.
A compelling read that at times is light hearted and funny, 7 Habits of Quality Obsessed Manufacturers is written for top performing quality professionals that want to give their company an edge.
An Executive Guide to Pharmaceutical Manufacturing Efficiency and the Effect of Environmental LegislationAugust 9, 2010 10:36 am | White Papers
This paper describes the use and waste of organic solvents in pharmaceutical manufacturing and the possible impact that greenhouse gas legislation, in the form of a carbon tax, may have on solvent usage and pharmaceutical manufacturing costs.
Recent studies covering plants in the U.S., UK and Germany show that controlling static electricity build-up is the key to preventing combustible cloud explosions.
This White Paper reviews the FDA’s Guidance addressing cardiovascular safety assessment during the development of new antidiabetic therapies for T2DM.